drugset / Trial / NCT07278362
Testosterone Replacement Therapy in Hypogonadal Patients With Prostate Cancer Under Active Surveillance
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is evaluate the safety of testosterone replacement therapy in men with newly diagnosed low-risk prostate cancer and hypogonadism on active surveillance.
Timeline
- Start
- 2026-05-31
- Primary completion
- 2031-05-31
- Completion
- 2032-05-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Testosterone Cypionate | Small molecule | 100 mg | Intramuscular |